Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure

Fig. 2

Serum from ACLF patients can increase the expression of IL-8 in hUC-MSCs. A Morphology of hUC-MSCs cultured in the serum of surviving or dead ACLF patients. B Proliferation of hUC-MSCs cultured in the serum of surviving or dead ACLF patients (n = 3). C Changes in the mRNA expression of 22 factors in hUC-MSCs cultured in the serum of surviving or dead ACLF patients. D ELISA was used to detect the expression of IL-8 in serum. E ELISA was used to detect the expression of IL-8 in the supernatant of hUC-MSCs. Scale bar = 50 μm. *P < 0.05; **P < 0.01; ***P < 0.001 (DPI:300)

Back to article page